2021
DOI: 10.3390/ijms221910188
|View full text |Cite
|
Sign up to set email alerts
|

Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination

Abstract: The ongoing pandemic coronavirus (CoV) disease 2019 (COVID-19) by severe acute respiratory syndrome CoV-2 (SARS-CoV-2) has already caused substantial morbidity, mortality, and economic devastation. Reverse genetic approaches to generate recombinant viruses are a powerful tool to characterize and understand newly emerging viruses. To contribute to the global efforts for countermeasures to control the spread of SARS-CoV-2, we developed a passage-free SARS-CoV-2 clone based on a bacterial artificial chromosome (B… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
50
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 41 publications
(63 citation statements)
references
References 27 publications
(36 reference statements)
1
50
0
Order By: Relevance
“…Viral titers were determined by plaque assays on Vero-ACE2 cells. SARS-CoV-2 wild-type and ORF8-deleted bacmid constructs were kindly provided by Armin Ensser (Institute of Virology, Erlangen, Germany) ( 49 ).…”
Section: Methodsmentioning
confidence: 99%
“…Viral titers were determined by plaque assays on Vero-ACE2 cells. SARS-CoV-2 wild-type and ORF8-deleted bacmid constructs were kindly provided by Armin Ensser (Institute of Virology, Erlangen, Germany) ( 49 ).…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant varicella zoster virus strain Oka (VZV-GFP) was generated by the use of bacmid technology, as described elsewhere [ 58 ], and virus propagation, including infection experiments for antiviral testing based on GFP fluorometry, was performed in a cell-associated manner on HFFs under standard conditions [ 26 , 59 , 60 ]. The generation and characterization of the recombinant SARS-CoV-2 virus d6-YFP in which viral ORF6 was replaced with EYFP has been described previously [ 41 , 61 ]. All SARS-CoV-2 infection experiments were performed under BSL-3 conditions.…”
Section: Methodsmentioning
confidence: 99%
“…To evaluate how the P323L and G671S mutations affected SARS-CoV-2 fitness and transmission, we used the SARS-CoV-2 Bacmid reverse genetic (RG) system to generate three isogenic SARS-CoV-2 variants (Spike D614G) containing the NSP12 WT, P323L, G671S, or P323L/G617S mutations 24 . We then examined their in vitro replication kinetics in Vero, Vero ACE2/TMPRSS2 , Huh-7, and Calu-3 cells at 33°C or 37°C.…”
Section: Resultsmentioning
confidence: 99%